These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11907160)

  • 1. Novel glutathione-dependent thiopurine prodrugs: evidence for enhanced cytotoxicity in tumor cells and for decreased bone marrow toxicity in mice.
    Gunnarsdottir S; Rucki M; Elfarra AA
    J Pharmacol Exp Ther; 2002 Apr; 301(1):77-86. PubMed ID: 11907160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct tissue distribution of metabolites of the novel glutathione-activated thiopurine prodrugs cis-6-(2-acetylvinylthio)purine and trans-6-(2-acetylvinylthio)guanine and 6-thioguanine in the mouse.
    Gunnarsdottir S; Elfarra AA
    Drug Metab Dispos; 2003 Jun; 31(6):718-26. PubMed ID: 12756203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glutathione-activated thiopurine prodrugs trans-6-(2-acetylvinylthio)guanine and cis-6-(2-acetylvinylthio)purine cause less in vivo toxicity than 6-thioguanine after single- and multiple-dose regimens.
    Gunnarsdottir S; Rucki M; Phillips LA; Young KM; Elfarra AA
    Mol Cancer Ther; 2002 Nov; 1(13):1211-20. PubMed ID: 12479702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen.
    Gunnarsdottir S; Elfarra AA
    Drug Metab Dispos; 2004 Mar; 32(3):321-7. PubMed ID: 14977866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human glutathione transferases catalyzing the bioactivation of anticancer thiopurine prodrugs.
    Eklund BI; Gunnarsdottir S; Elfarra AA; Mannervik B
    Biochem Pharmacol; 2007 Jun; 73(11):1829-41. PubMed ID: 17433263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting 6-thioguanine to the kidney with S-(guanin-6-yl)-L-cysteine.
    Elfarra AA; Duescher RJ; Hwang IY; Sicuri AR; Nelson JA
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1298-304. PubMed ID: 7562502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxides.
    Henderson ND; Plumb JA; Robins DJ; Workman P
    Anticancer Drug Des; 1996 Sep; 11(6):421-38. PubMed ID: 8836108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-dependent metabolism of cis-3-(9H-purin-6-ylthio)acrylic acid to yield the chemotherapeutic drug 6-mercaptopurine: evidence for two distinct mechanisms in rats.
    Gunnarsdottir S; Elfarra AA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):950-7. PubMed ID: 10454464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice.
    Kurowski V; Iven H
    Cancer Chemother Pharmacol; 1991; 28(1):7-14. PubMed ID: 2040036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
    Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
    J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of 6-thioguanine and 6-mercaptopurine from their 9-alkyl derivatives in mice.
    Nelson JA; Vidale E
    Cancer Res; 1986 Jan; 46(1):137-40. PubMed ID: 3940185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan.
    Gong XY; Yin YH; Huang ZJ; Lu B; Xu PH; Zheng H; Xiong FL; Xu HX; Xiong X; Gu XB
    Int J Pharm; 2012 Oct; 436(1-2):240-7. PubMed ID: 22750430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity mechanism-based prodrugs: glutathione-dependent bioactivation as a strategy for anticancer prodrug design.
    Zhang XY; Elfarra AA
    Expert Opin Drug Discov; 2018 Sep; 13(9):815-824. PubMed ID: 30101640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of pteroic acid-conjugated nitroheterocyclic phosphoramidates as folate receptor-targeted alkylating agents.
    Steinberg G; Borch RF
    J Med Chem; 2001 Jan; 44(1):69-73. PubMed ID: 11141089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells.
    van Gisbergen MW; Cebula M; Zhang J; Ottosson-Wadlund A; Dubois L; Lambin P; Tew KD; Townsend DM; Haenen GR; Drittij-Reijnders MJ; Saneyoshi H; Araki M; Shishido Y; Ito Y; Arnér ES; Abe H; Morgenstern R; Johansson K
    Mol Pharm; 2016 Jun; 13(6):2010-25. PubMed ID: 27093577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
    J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT).
    Monks NR; Calvete JA; Curtin NJ; Blakey DC; East SJ; Newell DR
    Br J Cancer; 2000 Jul; 83(2):267-9. PubMed ID: 10901381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase.
    Flader C; Liu J; Borch RF
    J Med Chem; 2000 Aug; 43(16):3157-67. PubMed ID: 10956224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic study of the interaction of glutathione with four antitumor disulfides: possible mechanism for cellular glutathione depletion.
    Kirkpatrick DL
    Chem Biol Interact; 1989; 69(2-3):225-34. PubMed ID: 2702703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
    del Olmo M; Alonso-Varona A; Castro B; Calle Y; Bilbao P; Palomares T
    Melanoma Res; 2000 Apr; 10(2):103-12. PubMed ID: 10803710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.